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This Month in the Journal
This month we present two review articles related to the
genetics of resistance to pathogens. Brownstein (p. 211)
discusses variability, in humans and among different in-
bred mouse strains, in susceptibility to viruses. He con-
siders both the celebrated recent example of a chemokine
receptor polymorphism that protects fromHIV infection
and also some more subtle, but possibly more represen-
tative, examples of polymorphisms that influence the
progression of viral disease. Poland (p. 215) focuses on
resistance to measles. He argues that antiviral antibody-
titer following vaccination represents a quantitative phe-
notype that reflects the host’s resistance to active path-
ogens. Genes that modulate responses to measles-virus
vaccination include the major histocompatibility loci
and theTAP genes, which function in antigen processing.
Multiple Endocrine Neoplasia Type I, by Bassett et al.
(p. 232)
Menin is the product of the recently clonedMEN1 gene,
which underlies type I multiple endocrine neoplasia, a
multiple-tumor disorder sometimes associated with pep-
tic ulcers. The dominant inheritance and variable clinical
course of MEN1 may indicate that menin serves as a
tumor suppressor, but its biochemical function has not
been demonstrated, and its sequence offers few clues.
Bassett et al. have used SSCP and DNA sequencing to
identify constitutionalMEN1 mutations in 61 of 63 un-
related MEN1 probands, 57 of whom had family his-
tories of the disease. In all, they identified 47 distinct
mutations, all point mutations or short deletions or in-
sertions. The mutations are found throughout the exons
and the exon junctions inMEN1, and the authors could
find no correlation between the type or location of the
mutation and the disease phenotype. The number of dis-
ease alleles and the frequent occurrence of de novo mu-
tations, often at hot spots with short repeat sequences,
suggest that haplotype analysis is of limited use for
diagnosis.
Mutation Analysis of Leiomyomatosis, by Ueki et al.
(p. 253)
The X-linked form of Alport syndrome (AS), a kidney
disease that also presents with eye defects and deafness,
results from mutations in the COL4A5 gene, encoding
one of the basement-membrane collagen chains. When
deletions in COL4A5 extend into the neighboring col-
lagen gene COL4A6, AS may be accompanied by diffuse
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leiomyomatosis (DL), a smooth-muscle tumor that char-
acteristically affects the esophagus. Curiously, larger ge-
netic lesions that completely eliminate both collagen
genes present only with AS. A critical region of
COL4A6, including some of its third intron, needs to
be spared for DL to occur. It has been proposed that
this intron contains structural or regulatory elements of
a third, as yet unidentified, gene that represses DL; al-
ternatively, a truncated form of COL4A6 might affect
smooth-muscle-cell growth directly. Ueki et al. now re-
port the sequence flanking the COL4A6 breakpoint in
a man with AS and DL, a first step toward resolving
this question. They find multiple consensus sequences
for topoisomerases surrounding the breakpoints. This
may suggest a mechanism for somatic deletion in the
COL4A5/ COL4A6 region, but the reason for pheno-
type differences between short and long COL4A6 de-
letions remains mysterious.
Pathogenic Mutation in Human Complex I, by van
den Heuvel et al. (p. 262)
Respiratory electron-transport chains create the proton
gradients needed for oxidative phosphorylation, and de-
fects in the electron carriers in this process can lead to
mitochondrial dysfunction and fatal encephalomyopa-
thies. Electron-transport complexes are large multicom-
ponent assemblies. Complex I contains the products of
at least 42 genes, most of which are nuclear; defects in
complex I function are readily identified at the biochem-
ical level, but genetic analysis has been lacking. van den
Heuvel et al. have undertaken to find the causal muta-
tions in a set of 20 complex I–deficient individuals. They
used homology to a known bovine sequence to identify
a human cDNA for the AQDQ subunit of complex I,
which they report here. One of the 20 individuals is
homozygous for a 5-bp insertion that shifts the reading
frame and extends the C-terminus of the AQDQprotein.
Stop Codons of NF1 as Splice Effectors, by Hoffmeyer
et al. (p. 269)
Nuclear-scanning mechanisms have been invoked to ex-
plain the sensitivity of intranuclear pre-mRNA splicing
and degradation to breaks in the reading frame of nas-
cent mRNA. Although appealing on teleological
grounds, and apparently supported in the case of fibrillin
mRNA splicing, nuclear scanning remains controversial
because there is no obvious mechanism for sensing pre-
mature-termination codons (PTCs) in the nucleus. Sev-
eral groups, including, now, Hoffmeyer et al., have
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sought alternative explanations for the skipping of exons
that contain PTCs. Working with RNA from cells from
people with type I neurofibromatosis, Hoffmeyer and
colleagues show that the processing of neurofibromin
mRNA does not respond simply to the presence of PTCs
in an internal exon. In sets of alleles with mutations in
exon 7 or exon 37 of the 61-exon NF1 gene, they find
that neighboring PTCs may have different effects on
mRNA splicing or stability. They further argue that pre-
dicted changes in RNA secondary structure, which may
introduce, remove, or destroy sequences that participate
in splicing, can account for the observed effects of PTCs
in this mRNA species.
Methylation Analysis in the DMPK Gene, by
Steinbach et al. (p. 278)
Methylation of DNA in CpG islands, noncoding regions
enriched for CpG dinucleotides, is associated with
changes in chromatin structure and transcriptional ac-
tivity. Here, Steinbach and coworkers describe a corre-
lation between a trinucleotide-repeat expansion in dis-
ease alleles of the myotonic dystrophy (DM) gene,
DMPK, and the complete methylation of CpG sites
within 1.5 kb of the trinucleotide repeat. This hyper-
methylation is found in cases of congenital DM but not
in later-onset cases or in unaffected individuals. Binding
of transcription factor Sp1 to a site near the repeat is
also inhibited, suggesting that with hypermethylation
comes a compact chromatin structure and reduced
DMPK expression. These observations are consistent
with other reports of effects of repeat expansion on local
methylation, but they do not readily account for the
dominant effects observed for the DM disease allele.
CYP1B1 Mutations in GLC3A, by Bejjani et al. (p.
325)
Here, Bejjani et al. report novel missense mutations in
the cytochrome P450 gene, CYP1B1, that lead to pri-
mary congenital glaucoma. The association of CYP1B1
with this condition was recently reported in some Turk-
ish glaucoma families. In the Saudi group studied by
Bejjani et al., the genetic basis of the disease appears to
be simpler. All affected individuals in 25 families were
either compound heterozygotes or homozygotes for one
of three missense mutations. These findings may be use-
ful for structure/function analysis, as well as for genetic
counseling in the Saudi population. The connection be-
tween these mutations and PCG, however, remains un-
clear; Bejjani and colleagues speculate that CYP1B1may
help degrade endogenous growth or differentiation fac-
tors during ocular development.
Susceptibility to Relapsing-Progressive MS, by
Hockertz et al. (p. 373)
Statistical analysis of human patients and experimental
work in animals indicate a role for T cell–receptor (TCR)
genes and class II MHC genes in multiple sclerosis (MS).
These candidate loci are plausible, because MS is a de-
myelination disorder that probably develops from au-
toimmune reactions. Nevertheless, detailed analysis has
proved difficult, in part because of complex allele-spe-
cific interactions between these loci. Hockertz and co-
workers argue here that two factors—the failure to dis-
tinguish among clinical forms of the disease and the
improper choice of control populations—have led re-
searchers to contradictory conclusions. Here, they em-
ploy family-based controls and stratify their group for
patterns of disease progression. They find that two dis-
tinct genotypes, consisting of different haplotypes at the
TCR locus and a polymorphism at the HLA-DR locus,
are significantly associated with the relapsing-progres-
sive—but not with the relapsing-remitting—form of the
disease.
mtDNA in Aboriginal Australians, by van Holst
Pellekaan et al. (p. 435)
mtDNA sequence divergence provides the basis formuch
of the genetic reconstruction of human migrations, but
this technique has not been applied extensively to Aus-
tralian aboriginal peoples. van Holst Pellekaan et al.
have acquired DNA samples from two culturally and
linguistically distinct groups, one from the north-central
“desert” region and one from the “riverine” region of
southeastern Australia. They also developed a novel met-
ric for mtDNA sequence divergence, BEPPI, the between-
population proportion index. This statistic describes the
relation between the number of sequence differences in
a sample and the proportion of all sequence pairings
that compare DNAs from different groups. They find
distinct distributions of mtDNA sequence types between
the desert and riverine peoples, consistent with their as-
sumed isolation. Comparisons with outside groups show
that the aboriginal populations are most closely related
to each other and that they are genetically nearer to New
Guinea highlanders than to other Pacific or African peo-
ples. This reconstruction is consistent with anthropo-
logical and genetic evidence suggesting a common foun-
der population for the present-day Australian aborigines
and New Guinea highlanders.
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